↓ Skip to main content

Cochrane Database of Systematic Reviews

Allergen‐specific oral immunotherapy for peanut allergy

Overview of attention for article published in Cochrane database of systematic reviews, September 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
337 Mendeley
Title
Allergen‐specific oral immunotherapy for peanut allergy
Published in
Cochrane database of systematic reviews, September 2012
DOI 10.1002/14651858.cd009014.pub2
Pubmed ID
Authors

Ulugbek Nurmatov, Iris Venderbosch, Graham Devereux, F Estelle R Simons, Aziz Sheikh

Abstract

Peanut allergy is one of the most common forms of food allergy encountered in clinical practice.  In most cases, it does not spontaneously resolve; furthermore, it is frequently implicated in acute life-threatening reactions. The current management of peanut allergy centres on meticulous avoidance of peanuts and peanut-containing foods. Allergen-specific oral immunotherapy (OIT) for peanut allergy aims to induce desensitisation and then tolerance to peanut, and has the potential to revolutionise the management of peanut allergy. However, at present there is still considerable uncertainty about the effectiveness and safety of this approach.

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 337 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Korea, Republic of 1 <1%
Canada 1 <1%
Slovenia 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 330 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 12%
Student > Master 41 12%
Researcher 34 10%
Other 26 8%
Student > Ph. D. Student 26 8%
Other 54 16%
Unknown 114 34%
Readers by discipline Count As %
Medicine and Dentistry 107 32%
Nursing and Health Professions 25 7%
Agricultural and Biological Sciences 20 6%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Immunology and Microbiology 9 3%
Other 37 11%
Unknown 127 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2020.
All research outputs
#1,051,258
of 25,934,828 outputs
Outputs from Cochrane database of systematic reviews
#2,009
of 13,163 outputs
Outputs of similar age
#5,754
of 188,358 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 228 outputs
Altmetric has tracked 25,934,828 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,163 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,358 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.